87 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
) (a) words of any gender include each other gender and neuter form; (b) words using the singular or plural number also include the plural or singular … in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless
8-K
EX-10.1
at65ubar
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
37nss8s
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
jgj bxovqcwsmmdk
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
e7gp9j1s8mrwxh53
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
b5oa3
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.2
t0fnz8in788 1gnptg8
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.4
r4nftav4
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
elcdtnr ti5w
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
pmjj5m y3qstc
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
k12hidgcwqlu zd
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
2hvzkg6928i
10 Aug 20
Tender and Support Agreement
9:48pm
DEFA14A
qwwp68kiyk7e5
4 Jun 19
Additional proxy soliciting materials
5:07pm
8-K
EX-10.1
orred 8k8
9 Aug 18
Entry into a Material Definitive Agreement
9:05am